Hayana Ramos Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hayana Ramos Lima has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Manoela Carrera
Universidade do Estado da Bahia
6 shared publications - Gabriela Botelho Martins
Universidade Federal da Bahia
5 shared publications - Alena Ribeiro Alves Peixoto Medrado
Universidade Federal da Bahia
4 shared publications - Juliana Borges de Lima Dantas
Escola Bahiana de Medicina e Saúde Pública. BA, Brazil. Colégio Adventista da Bahia. BA, Brazil
4 shared publications - Amanda de Sousa Melo
Department of Life Sciences, State University of Bahia, Salvador, Brazil
2 shared publications - Agda Santana Costa
Universidade do Estado da Bahia (UNEB), Salvador, Bahia, Brasil
1 shared publication
Latest Publications
- 11 July 2024
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (8) , 1-10
Might photobiomodulation therapy interfere with the frequency of severe mucositis and oral candidiasis? A retrospective analysis in patients with head and neck carcinoma
Purpose Considering the tumor in the oral cavity or the oropharynx and nasopharynx region might be an aggravating factor for oral mucositis (OM) manifestation, the present study aimed to evaluate whether the location of the tumor and the use of photobiomodulation therapy (PBMT) might affect the frequency of oral candidiasis (OC) during radiotherapy (RT) and/or chemotherapy (CT) treatments. Methods The medial records of seventy-four patients with head and neck cancer treated in a public service from 2016 to 2019 were evaluated. All these patients were submitted to RT in an accumulated dose of 48 to 70 Gy of radiation. Data about OM and OC were collected and presented according to the application of a therapeutic protocol with laser photobiomodulation (PBMT) to control oral mucositis, or not (No-PBM), and the location of tumor (head and neck or oral cavity). In the PBMT group patients, a low-power laser device composed of InGaAlP diode (maximum output power of 86.7 mW, active tip area of 0.1256 cm2, and continuous wavelength of 660 nm), was applied to the lips (three points each), right and left jugal mucosa (three points each), the limit between hard and soft palate (three points), buccal floor/sublingual gland (one point), lateral edge of the tongue (three points on each side), and back of the tongue (six points), three times weekly, for 5 weeks. The dosimetry used in each application was 2 J for 3 s, thus totaling 56 J. The correlation between clinical characteristics such as age, tumor size (T), metastatic lymph node (N), number of RT and CT sessions, candidiasis, and OM were analyzed. Results Mucositis grades 1 and 2 were the most common among all patients, especially before the 12th radiotherapy session, regardless of the treatment with PBM (p > 0.05). Additionally, no difference in the grade of OM and OC was significantly observed when comparing the two laser therapy groups. OC was more frequent after the 12th radiotherapy session in all groups. Nonetheless, OM and OC had a different correlation regarding to tumor location (head and neck and oral cavity) being PBMT a positive therapy to delay OM. It was observed a positive and statistically significant correlation between tumors at oral cavity and OM, regardless PBMT (R = 0.84, p < 0.05 to PBMT and R = 0.13, p < 0.05 to No-PBM). Otherwise, OC was positively correlated to local metastasis in patients with oral tumors undergoing PBMT (R = 0.84, p < 0.05). Conclusion Patients with oral cavity tumor presented more OM, especially high grades, then patients with tumors in other regions of the head and neck, which seems to be related to the irradiation parameters of radiotherapy and/or with the limitation of conduction of PBMT in tumor areas. OM and OC were not changed by PBMT, although it helped to reduce the incidence of severe cases of OM.
- 11 July 2024
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (8) , 1-10
Might photobiomodulation therapy interfere with the frequency of severe mucositis and oral candidiasis? A retrospective analysis in patients with head and neck carcinoma
Purpose Considering the tumor in the oral cavity or the oropharynx and nasopharynx region might be an aggravating factor for oral mucositis (OM) manifestation, the present study aimed to evaluate whether the location of the tumor and the use of photobiomodulation therapy (PBMT) might affect the frequency of oral candidiasis (OC) during radiotherapy (RT) and/or chemotherapy (CT) treatments. Methods The medial records of seventy-four patients with head and neck cancer treated in a public service from 2016 to 2019 were evaluated. All these patients were submitted to RT in an accumulated dose of 48 to 70 Gy of radiation. Data about OM and OC were collected and presented according to the application of a therapeutic protocol with laser photobiomodulation (PBMT) to control oral mucositis, or not (No-PBM), and the location of tumor (head and neck or oral cavity). In the PBMT group patients, a low-power laser device composed of InGaAlP diode (maximum output power of 86.7 mW, active tip area of 0.1256 cm2, and continuous wavelength of 660 nm), was applied to the lips (three points each), right and left jugal mucosa (three points each), the limit between hard and soft palate (three points), buccal floor/sublingual gland (one point), lateral edge of the tongue (three points on each side), and back of the tongue (six points), three times weekly, for 5 weeks. The dosimetry used in each application was 2 J for 3 s, thus totaling 56 J. The correlation between clinical characteristics such as age, tumor size (T), metastatic lymph node (N), number of RT and CT sessions, candidiasis, and OM were analyzed. Results Mucositis grades 1 and 2 were the most common among all patients, especially before the 12th radiotherapy session, regardless of the treatment with PBM (p > 0.05). Additionally, no difference in the grade of OM and OC was significantly observed when comparing the two laser therapy groups. OC was more frequent after the 12th radiotherapy session in all groups. Nonetheless, OM and OC had a different correlation regarding to tumor location (head and neck and oral cavity) being PBMT a positive therapy to delay OM. It was observed a positive and statistically significant correlation between tumors at oral cavity and OM, regardless PBMT (R = 0.84, p < 0.05 to PBMT and R = 0.13, p < 0.05 to No-PBM). Otherwise, OC was positively correlated to local metastasis in patients with oral tumors undergoing PBMT (R = 0.84, p < 0.05). Conclusion Patients with oral cavity tumor presented more OM, especially high grades, then patients with tumors in other regions of the head and neck, which seems to be related to the irradiation parameters of radiotherapy and/or with the limitation of conduction of PBMT in tumor areas. OM and OC were not changed by PBMT, although it helped to reduce the incidence of severe cases of OM.
- Open Access
- 16 October 2023
- Published by Springer Nature in Research Square
Might low-level laser therapy interfere with the frequency of severe mucositis and oral candidiasis? A retrospective analysis in patients with head and neck carcinoma
Purpose Considering the tumor in the oral cavity or the oropharynx and nasopharynx region might be an aggravating factor for Oral Mucositis (OM) manifestation, the present study aimed to evaluate whether the location of the tumor and the use of Low-level laser therapy (LLLT) might affect the frequency of oral candidiasis during radiotherapy (RT) and/or chemotherapy (CT) treatments. Methods Seventy-four patients with head and neck cancer were evaluated from 2016 to 2019. All these patients were submitted to RT in an accumulated dose of 48 to 70 Gy of radiation. These patients were followed with OM and OC treatment and divided into two groups: No-LLLT (SHAM group) and LLLT (Laser group). The correlation between clinical characteristics such as age, tumor size (T), metastatic lymph node (N), number of RT and CT sessions, candidiasis, and OM were analyzed. Results Mucositis grades 1 and 2 were the most common among all patients, especially before the 12th radiotherapy session, regardless of the treatment with LLLT. Additionally, no difference in the grade of OM and OC was significantly observed when comparing the two laser therapy groups. OC was more frequent after the 12th radiotherapy session in all groups. Conclusion OM and OC was not changed by LLLT, although it helped to reduce the incidence of severe cases of OM. Patients with oral cavity tumor presented more OM, especially high grades, then patients with tumors in other regions of the head and neck, which seems to be related to the irradiation parameters of radiotherapy and/or with the limitation of conduction of LLLT in tumor areas.
- 16 October 2023
- Published by Springer Nature in Research Square
Open AccessMight low-level laser therapy interfere with the frequency of severe mucositis and oral candidiasis? A retrospective analysis in patients with head and neck carcinoma
Purpose Considering the tumor in the oral cavity or the oropharynx and nasopharynx region might be an aggravating factor for Oral Mucositis (OM) manifestation, the present study aimed to evaluate whether the location of the tumor and the use of Low-level laser therapy (LLLT) might affect the frequency of oral candidiasis during radiotherapy (RT) and/or chemotherapy (CT) treatments. Methods Seventy-four patients with head and neck cancer were evaluated from 2016 to 2019. All these patients were submitted to RT in an accumulated dose of 48 to 70 Gy of radiation. These patients were followed with OM and OC treatment and divided into two groups: No-LLLT (SHAM group) and LLLT (Laser group). The correlation between clinical characteristics such as age, tumor size (T), metastatic lymph node (N), number of RT and CT sessions, candidiasis, and OM were analyzed. Results Mucositis grades 1 and 2 were the most common among all patients, especially before the 12th radiotherapy session, regardless of the treatment with LLLT. Additionally, no difference in the grade of OM and OC was significantly observed when comparing the two laser therapy groups. OC was more frequent after the 12th radiotherapy session in all groups. Conclusion OM and OC was not changed by LLLT, although it helped to reduce the incidence of severe cases of OM. Patients with oral cavity tumor presented more OM, especially high grades, then patients with tumors in other regions of the head and neck, which seems to be related to the irradiation parameters of radiotherapy and/or with the limitation of conduction of LLLT in tumor areas.
- Open Access
- 4 March 2023
- Published by Universidade Tecnologica Federal do Parana (UTFPR) in Revista Brasileira de Qualidade de Vida
- Vol. 15
Avaliação da qualidade de vida em deglutição de pacientes com câncer de cabeça e pescoço em tratamento radio/quimioterápico submetidos à fotobiomodulação laser para mucosite oral
OBJETIVO: Avaliar a qualidade de vida em deglutição de pacientes com câncer de cabeça e pescoço em tratamento radio/quimioterápico submetidos à fotobiomodulação laser para mucosite oral.MÉTODOS: Participaram do estudo 28 pacientes acometidos pelo câncer de cabeça e pescoço em tratamento oncológico por meio de radioterapia exclusiva ou associada à quimioterapia. Os indivíduos foram alocados aleatoriamente em dois grupos, laser on (n=19) e laser sham (n=9), sendo este último o grupo controle. A qualidade de vida em deglutição foi avaliada através do MD Anderson Dysphagia Inventory (MDADI). As análises ocorreram na 1ª, na 12ª e na 24ª sessões de radioterapia. Foram utilizados os testes t-student para comparação entre grupos e ANOVA e pós-teste de Bonferroni para as medidas com o decorrer do tempo.RESULTADOS: Apenas o domínio físico demonstrou diferença estatisticamente significativa no grupo laser on ao longo do tempo (p=0,03); e, entre a 1ª e a 12ª sessões de radioterapia no grupo laser sham (p=0,01).CONCLUSÕES: Embora com limitações, o estudo demonstrou que houve piora da qualidade de vida em deglutição em todos os pacientes, especialmente no domínio físico, ao longo dos períodos estudados.
- 4 March 2023
- Published by Universidade Tecnologica Federal do Parana (UTFPR) in Revista Brasileira de Qualidade de Vida
- Vol. 15
Open AccessAvaliação da qualidade de vida em deglutição de pacientes com câncer de cabeça e pescoço em tratamento radio/quimioterápico submetidos à fotobiomodulação laser para mucosite oral
OBJETIVO: Avaliar a qualidade de vida em deglutição de pacientes com câncer de cabeça e pescoço em tratamento radio/quimioterápico submetidos à fotobiomodulação laser para mucosite oral.MÉTODOS: Participaram do estudo 28 pacientes acometidos pelo câncer de cabeça e pescoço em tratamento oncológico por meio de radioterapia exclusiva ou associada à quimioterapia. Os indivíduos foram alocados aleatoriamente em dois grupos, laser on (n=19) e laser sham (n=9), sendo este último o grupo controle. A qualidade de vida em deglutição foi avaliada através do MD Anderson Dysphagia Inventory (MDADI). As análises ocorreram na 1ª, na 12ª e na 24ª sessões de radioterapia. Foram utilizados os testes t-student para comparação entre grupos e ANOVA e pós-teste de Bonferroni para as medidas com o decorrer do tempo.RESULTADOS: Apenas o domínio físico demonstrou diferença estatisticamente significativa no grupo laser on ao longo do tempo (p=0,03); e, entre a 1ª e a 12ª sessões de radioterapia no grupo laser sham (p=0,01).CONCLUSÕES: Embora com limitações, o estudo demonstrou que houve piora da qualidade de vida em deglutição em todos os pacientes, especialmente no domínio físico, ao longo dos períodos estudados.
- Open Access
- 1 January 2023
- Published by Cadernos de Fe e Cultura, Oculum Ensaios, Reflexao, Revista de Ciencias Medicas e Revista de Educacao da PUC-Campinas in Revista de Ciências Médicas
- Vol. 32
Atualização das apresentações clínicas que cursam com ageusia e disgeusia
Compreender as alterações gustativas é relevante para identificação de outras doenças ou agravos à saúde quando excluídos a infecção por SARS-CoV-2 e o tratamento antineoplásico. Assim, é necessário que os profissionais de saúde saibam reconhecer doenças queestão associadas às alterações de paladar, quando descartada a infecção em razão do coronavírus. Foram realizadas buscas nas bases de dados PubMed, MedLine e SciELO, através dos descritores: “Ageusia” e “Disgeusia”, limitando o período de busca entre os anos de 2017 a 2021. Foram incluídos artigos originais, no idioma inglês. Os dados obtidos foram submetidos a uma análise quantitativa simples, selecionando os resumos pertinentes a essa revisão. Foram excluídos artigos que relacionaram tais alterações de paladar ao coronavírus e ao tratamento antineoplásico. Foram selecionados seis estudos, dos 61 encontrados, que em conjunto analisaram uma amostra total de 573 indivíduos. O sabor metálico foi a alteração de paladar relatada com maior frequência, já o sabor doce foi o mais facilmente detectado pelos indivíduos testados, havendo maior facilidade de percepção entre a população feminina. A maioria dos indivíduos relata que a frequência com que este sintoma se apresenta é diária, mas a duração de persistência do sintoma não é descrita. É necessário compreender as alterações de paladar no contexto de outras doenças, quando excluída o coronavírus.
- 1 January 2023
- Published by Cadernos de Fe e Cultura, Oculum Ensaios, Reflexao, Revista de Ciencias Medicas e Revista de Educacao da PUC-Campinas in Revista de Ciências Médicas
- Vol. 32
Open AccessAtualização das apresentações clínicas que cursam com ageusia e disgeusia
Compreender as alterações gustativas é relevante para identificação de outras doenças ou agravos à saúde quando excluídos a infecção por SARS-CoV-2 e o tratamento antineoplásico. Assim, é necessário que os profissionais de saúde saibam reconhecer doenças queestão associadas às alterações de paladar, quando descartada a infecção em razão do coronavírus. Foram realizadas buscas nas bases de dados PubMed, MedLine e SciELO, através dos descritores: “Ageusia” e “Disgeusia”, limitando o período de busca entre os anos de 2017 a 2021. Foram incluídos artigos originais, no idioma inglês. Os dados obtidos foram submetidos a uma análise quantitativa simples, selecionando os resumos pertinentes a essa revisão. Foram excluídos artigos que relacionaram tais alterações de paladar ao coronavírus e ao tratamento antineoplásico. Foram selecionados seis estudos, dos 61 encontrados, que em conjunto analisaram uma amostra total de 573 indivíduos. O sabor metálico foi a alteração de paladar relatada com maior frequência, já o sabor doce foi o mais facilmente detectado pelos indivíduos testados, havendo maior facilidade de percepção entre a população feminina. A maioria dos indivíduos relata que a frequência com que este sintoma se apresenta é diária, mas a duração de persistência do sintoma não é descrita. É necessário compreender as alterações de paladar no contexto de outras doenças, quando excluída o coronavírus.
- Open Access
- 24 October 2022
- Published by Termedia Sp. z.o.o. in Contemporary Oncology
- Vol. 26 (3) , 174-179
Heart protective effects of cardioactive drugs associated with antineoplastic treatment against breast cancer
The prevalence of breast cancer in women is a fundamental problem in public health worldwide. There is consensual evidence that many chemotherapeutic agents might have harmful effects on the cardiovascular system of patients. The cardiotoxicity of chemotherapeutic drugs might lead to ventricular...
- 24 October 2022
- Published by Termedia Sp. z.o.o. in Contemporary Oncology
- Vol. 26 (3) , 174-179
Open AccessHeart protective effects of cardioactive drugs associated with antineoplastic treatment against breast cancer
The prevalence of breast cancer in women is a fundamental problem in public health worldwide. There is consensual evidence that many chemotherapeutic agents might have harmful effects on the cardiovascular system of patients. The cardiotoxicity of chemotherapeutic drugs might lead to ventricular...
- 15 February 2022
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 30 (6) , 4897-4904
Impact of photobiomodulation for oral mucositis on body weight and BMI of patients with head and neck cancer
Purpose To evaluate the impact of photobiomodulation for oral mucositis on body weight and body mass index (BMI) in head and neck cancer patients. Methods Patients were separated into two groups: photobiomodulation (PBM) (n = 17) and SHAM (n = 19). Participants assigned to the PBM group received the photobiomodulation therapy on alternate days at 33 different sites of the oral mucosa (1 J for 10 s per application point) using a low-power aluminum gallium arsenide (AsGaAl) laser device with a maximum output power of 86.7 mW and a wavelength of 660 nm (red). The same protocol was performed in patients allocated in the SHAM group but with the device turned off. At the first and twenty-fourth radiotherapy sessions, participants from both groups underwent an intraoral examination to assess the presence or absence of mucositis using the WHO scale, and measurements of weight and height for BMI calculation were undertaken. Results All patients had significant differences in weight and BMI throughout the study period. Patients in the PBM group lost less weight (p < 0.01) and had a reduced BMI loss (p < 0.01) in comparison to patients in the SHAM group. Although PBM did not prevent oral mucositis, it decreased its severity (p < 0.01). Conclusion Photobiomodulation for oral mucositis reduced weight loss and prevented a reduction in BMI in patients who underwent chemoradiotherapy for head and neck cancer. Retrospectively registered at https://data.mendeley.com//datasets/4kd7s49wk4/1.
- 15 February 2022
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 30 (6) , 4897-4904
Impact of photobiomodulation for oral mucositis on body weight and BMI of patients with head and neck cancer
Purpose To evaluate the impact of photobiomodulation for oral mucositis on body weight and body mass index (BMI) in head and neck cancer patients. Methods Patients were separated into two groups: photobiomodulation (PBM) (n = 17) and SHAM (n = 19). Participants assigned to the PBM group received the photobiomodulation therapy on alternate days at 33 different sites of the oral mucosa (1 J for 10 s per application point) using a low-power aluminum gallium arsenide (AsGaAl) laser device with a maximum output power of 86.7 mW and a wavelength of 660 nm (red). The same protocol was performed in patients allocated in the SHAM group but with the device turned off. At the first and twenty-fourth radiotherapy sessions, participants from both groups underwent an intraoral examination to assess the presence or absence of mucositis using the WHO scale, and measurements of weight and height for BMI calculation were undertaken. Results All patients had significant differences in weight and BMI throughout the study period. Patients in the PBM group lost less weight (p < 0.01) and had a reduced BMI loss (p < 0.01) in comparison to patients in the SHAM group. Although PBM did not prevent oral mucositis, it decreased its severity (p < 0.01). Conclusion Photobiomodulation for oral mucositis reduced weight loss and prevented a reduction in BMI in patients who underwent chemoradiotherapy for head and neck cancer. Retrospectively registered at https://data.mendeley.com//datasets/4kd7s49wk4/1.
- 1 June 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 43, 31-38
Nutritional supplements in the management of oral mucositis in patients with head and neck cancer: Narrative literary review
- 1 June 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 43, 31-38
Nutritional supplements in the management of oral mucositis in patients with head and neck cancer: Narrative literary review
- 6 May 2021
- Published by Even3
O CIRURGIÃO-DENTISTA E O CUIDADO INTEGRAL AO PACIENTE HOSPITALIZADO
A saúde bucal não pode ser compreendida de forma dissociada da saúde sistêmica, tampouco o ambiente do consultório odontológico é local exclusivo para a atuação dos cirurgiões-dentistas. Este material revisa aspectos anatômicos e microbiológicos da cavidade oral, ressaltando a importância do controle do biofilme oral. Ainda, há um alerta sobre a relevância da odontologia hospitalar, como um dos cenários de atuação do cirurgião-dentista no cuidado à saúde em todos os níveis, da educação em saúde e prevenção à recuperação e reabilitação.
- 6 May 2021
- Published by Even3
O CIRURGIÃO-DENTISTA E O CUIDADO INTEGRAL AO PACIENTE HOSPITALIZADO
A saúde bucal não pode ser compreendida de forma dissociada da saúde sistêmica, tampouco o ambiente do consultório odontológico é local exclusivo para a atuação dos cirurgiões-dentistas. Este material revisa aspectos anatômicos e microbiológicos da cavidade oral, ressaltando a importância do controle do biofilme oral. Ainda, há um alerta sobre a relevância da odontologia hospitalar, como um dos cenários de atuação do cirurgião-dentista no cuidado à saúde em todos os níveis, da educação em saúde e prevenção à recuperação e reabilitação.
- Open Access
- 18 June 2019
- Published by Escola Bahiana de Medicina e Saude Publica in Journal of Dentistry & Public Health
- Vol. 10 (1) , 41-47
Perfil epidemiológico do paciente oncológico em um serviço de odontologia
INTRODUÇÃO: A crescente incidência das neoplasias malignas no Brasil aponta como um constante objetivo o conhecimento do perfil sociocultural da população portadora de câncer. OBJETIVO: Caracterizar a população atendida no serviço de Odontologia da Unidade de Alta Complexidade em Oncologia Nsa. Sra. De Fátima (Salvador - BA), no ano de 2017. METODOLOGIA: Trata-se de um estudo de corte transversal descritivo. Dados relativos a sexo, idade, escolaridade, ocupação, uso de álcool e/ou tabaco, localização do tumor primário e tipo de tratamento instituído foram coletados de 61 prontuários hospitalares. RESULTADOS: Houve predominância de homens (65,6%) entre 60 e 69 anos (34,4%) e escolaridade compatível com ensino fundamental completo/incompleto (57,3%). O uso associado de álcool e tabaco esteve presente em 42,6% da amostra e as neoplasias mais frequentes foram laringe, laringofaringe e glote (27,9%), seguidas de mama (18%). CONCLUSÃO: A população de pacientes submetidos à radioterapia de cabeça e pescoço foi majoritariamente composta por indivíduos do sexo masculino, idade avançada, baixa escolaridade, tabagistas e etilistas e diagnosticados tardiamente. O grupo submetido a quimioterapia isolada foi composto em sua maioria por mulheres entre 40 e 49 anos, portadoras de neoplasias malignas de mama. Os dados aqui relatados apontam a necessidade de estratégias de prevenção e combate ao câncer, direcionadas ao perfil de risco descrito.
- 18 June 2019
- Published by Escola Bahiana de Medicina e Saude Publica in Journal of Dentistry & Public Health
- Vol. 10 (1) , 41-47
Open AccessPerfil epidemiológico do paciente oncológico em um serviço de odontologia
INTRODUÇÃO: A crescente incidência das neoplasias malignas no Brasil aponta como um constante objetivo o conhecimento do perfil sociocultural da população portadora de câncer. OBJETIVO: Caracterizar a população atendida no serviço de Odontologia da Unidade de Alta Complexidade em Oncologia Nsa. Sra. De Fátima (Salvador - BA), no ano de 2017. METODOLOGIA: Trata-se de um estudo de corte transversal descritivo. Dados relativos a sexo, idade, escolaridade, ocupação, uso de álcool e/ou tabaco, localização do tumor primário e tipo de tratamento instituído foram coletados de 61 prontuários hospitalares. RESULTADOS: Houve predominância de homens (65,6%) entre 60 e 69 anos (34,4%) e escolaridade compatível com ensino fundamental completo/incompleto (57,3%). O uso associado de álcool e tabaco esteve presente em 42,6% da amostra e as neoplasias mais frequentes foram laringe, laringofaringe e glote (27,9%), seguidas de mama (18%). CONCLUSÃO: A população de pacientes submetidos à radioterapia de cabeça e pescoço foi majoritariamente composta por indivíduos do sexo masculino, idade avançada, baixa escolaridade, tabagistas e etilistas e diagnosticados tardiamente. O grupo submetido a quimioterapia isolada foi composto em sua maioria por mulheres entre 40 e 49 anos, portadoras de neoplasias malignas de mama. Os dados aqui relatados apontam a necessidade de estratégias de prevenção e combate ao câncer, direcionadas ao perfil de risco descrito.